Atlas Trials

Can Platelets/Lymphocytes Rate Be New Serological Index for Prognosis of Coronary Heart Disease Complicated With Impaired Glucose Tolerance: Basic Principles and Experimental Design

Clinical trial NCT02149056 · COMPLETED

Trial details

NCT number
NCT02149056
Sponsor
Affiliated Hospital of Hebei University
Status
COMPLETED
Study type
OBSERVATIONAL
Coronary Heart Disease Complicated With Impaired Glucose Tolerance
Start date
2013-08-01
Primary completion
2013-08-01
Enrollment
447

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.